Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100127003213N9Phase 3Completed
Phase 3 trial of gabapentin in postoperative pain (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100127003213N9.